Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
Marcain Polyamp Steripack 0.5%.
| Pharmaceutical Form |
|---|
|
Injection. |
Bupivacaine Hydrochloride BP 5.28 mg/ml equivalent to bupivacaine hydrochloride anhydrous 5.0 mg/ml.
Excipient(s) with known effect: Each millilitre (ml) of Marcain Polyamp Steripack contains 3.15 mg of sodium, equivalent to 31.4 mg per 10 ml ampoule.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Bupivacaine |
Bupivacaine is an amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation. |
| List of Excipients |
|---|
|
Sodium chloride (tonicity contributor) |
10 ml and 20 ml polypropylene ampoules PolyampR. Cartons contain 5 or 10 ampoules. Not all pack sizes may be marketed.
Aspen Pharma Trading Limited, 3016 Lake Drive, Citywest Business Campus, Dublin 24, Ireland
PL 39699/0079
4th June 2002
| Drug | Countries | |
|---|---|---|
| MARCAIN | Hong Kong, Ireland, Japan, Lithuania, Malta, New Zealand, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
